Literature DB >> 28880377

Detection of clinically relevant early genomic lesions in B-cell malignancies from circulating tumour DNA using a single hybridisation-based next generation sequencing assay.

Piers A Blombery1, Georgina L Ryland1, John Markham1, Jerick Guinto1, Meaghan Wall2,3,4, Michelle McBean1, Kate Jones1, Ella R Thompson1,3, Daniel L Cameron5, Anthony T Papenfuss1,3,5, Miles H Prince1,3, Michael Dickinson1,3, David Alan Westerman1,3.   

Abstract

Entities:  

Keywords:  ctDNA; lymphoma; myeloma; next generation sequencing

Mesh：

Substances：

Year:  2017        PMID： 28880377     DOI： 10.1111/bjh.14919

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax.

Authors:  Piers Blombery; Ella R Thompson; Tamia Nguyen; Richard W Birkinshaw; Jia-Nan Gong; Xiangting Chen; Michelle McBean; Rachel Thijssen; Thomas Conway; Mary Ann Anderson; John F Seymour; David A Westerman; Peter E Czabotar; David C S Huang; Andrew W Roberts
Journal:  Blood       Date:  2020-03-05       Impact factor: 22.113

Review 2.  Role of Circulating Tumor DNA in Hematological Malignancy.

Authors:  Miho Ogawa; Kazuaki Yokoyama; Seiya Imoto; Arinobu Tojo
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

3.  Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS.

Authors:  Gareth P Gregory; Michael Dickinson; Costas K Yannakou; Jonathan Wong; Piers Blombery; Greg Corboy; Lev Kats; Tim M E Crozier; Beena Kumar; H Miles Prince; Stephen S Opat; Jake Shortt
Journal:  Hemasphere       Date:  2019-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.